(Q39342356)

11 September 2017

title

Humoral antibodies to acetylcholine receptor in patients with myasthenia gravis (English)

2 references

11 September 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A51144

8 April 2022

0 references

0 references

1 reference

acetylcholine receptor

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A51144

8 April 2022

A. Aharonov

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A51144

8 April 2022

O. Abramsky

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A51144

8 April 2022

R. Tarrab-Hazdai

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A51144

8 April 2022

S. Fuchs

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A51144

8 April 2022

language of work or name

English

0 references

publication date

1 August 1975

1 reference

11 September 2017

23 August 1975

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=51144

full work available at URL

8 April 2022

https://api.elsevier.com/content/article/PII:S0140673675927798?httpAccept=text/xml

1 reference

10.1016/S0140-6736(75)92779-8

DOI

https://api.crossref.org/works/10.1016/S0140-6736(75)92779-8

https://api.elsevier.com/content/article/PII:S0140673675927798?httpAccept=text/plain

8 April 2022

1 reference

10.1016/S0140-6736(75)92779-8

DOI

https://api.crossref.org/works/10.1016/S0140-6736(75)92779-8

8 April 2022

1 reference

11 September 2017

1 reference

11 September 2017

issue

7930

1 reference

11 September 2017

page(s)

340-342

1 reference

Myasthenia gravis as an autoimmune disease: clinical aspects

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992779-8

7 January 2021

The pathology of the thymus gland in myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992779-8

7 January 2021

Treatment of myasthenia gravis with prednisone

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992779-8

7 January 2021

Gradually increasing doses of prednisone in myasthenia gravis. Reducing the hazards of treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992779-8

7 January 2021

Thymic lymphocyte function in myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992779-8

7 January 2021

Destruction of cultured thymus cells by autologous lymphocytes from a patient with myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992779-8

7 January 2021

Myasthenia gravis. Immunological relationship between striated muscle and thymus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992779-8

7 January 2021

The autoimmune response in myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992779-8

7 January 2021

Changes in serum complement activity in patients with myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992779-8

7 January 2021

Autoimmune Response to Acetylcholine Receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992779-8

7 January 2021

Neurophysiological signs of myasthenia in rabbits after receptor antibody development

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992779-8

7 January 2021

Experimental autoimmune myasthenia induced in monkeys by purified acetylcholine receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992779-8

7 January 2021

Some effects of extracts of thymus glands removed from patients with myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992779-8

7 January 2021

Neuromuscular blocking activity in the blood of patients with myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992779-8

7 January 2021

Effect of serum and serum globulin of patients with myasthenia gravis on neuromuscular transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992779-8

7 January 2021

Serum globulin in myasthenia gravis: inhibition of alpha-bungarotoxin binding to acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992779-8

7 January 2021

Myasthenia gravis: a serum factor blocking acetylcholine receptors of the human neuromuscular junction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992779-8

7 January 2021

Cell-mediated immunity to myelin basic protein in acute disseminated encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992779-8

7 January 2021

The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992779-8

7 January 2021

Polymyositis and myasthenia gravis: immunodeficiency disorders involving skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992779-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992779-8

1 reference

7 January 2021

THE EFFECT OF HAEMODIALYSIS IN MYASTHENIA GRAVIS

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992779-8

7 January 2021

Neuromuscular Junction in Myasthenia Gravis: Decreased Acetylcholine Receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992779-8

7 January 2021

Search for a neuromuscular blocking agent in the blood of patients with myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2992779-8

7 January 2021

10.1016/S0140-6736(75)92779-8

Identifiers

DOI

1 reference

11 September 2017

1 reference